Mulmit

NIKA PHARMACEUTICALS, INCNIKA PHARMACEUTICALS, INC

NIKA OTC

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2024-12-310-95,792-95,7920
2023-12-310-64,833-64,8330
2022-12-310-3,183,715-3,183,7150
2021-12-310-14,712-14,7120

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2025-03-18Savov Dimitar SlavchevCEO, CFO, President2,000,000
2023-06-02NIKA PHARMACEUTICALS, INCPresident, CEO, CFO3,500,000
2023-01-31NIKA PHARMACEUTICALS, INCPresident, CEO, CFO1,500,000
2023-01-10NIKA PHARMACEUTICALS, INCPresident, CEO, CFO6,300,000
2022-10-24NIKA PHARMACEUTICALS, INCPresident, CEO, CFO3,000,000
2022-09-26NIKA PHARMACEUTICALS, INCPresident, CEO, CFO1,250,000
2022-09-12NIKA PHARMACEUTICALS, INCPresident, CEO, CFO7,000,000
2022-07-20NIKA PHARMACEUTICALS, INCSecretary145,000,000
2022-07-20NIKA PHARMACEUTICALS, INCPresident, CEO, CFO333,181,000
2022-04-29NIKA PHARMACEUTICALS, INCSecretary5,000,000
2022-04-13NIKA PHARMACEUTICALS, INCPresident, CEO, CFO10,000,000
2022-04-13NIKA PHARMACEUTICALS, INCPresident, CEO, CFO11,489,000

8-K events

FiledItems
2024-10-16Change in certifying accountant · Financial statements and exhibits
2024-10-01Change in certifying accountant
2024-08-27Completed acquisition or disposition of assets · Financial statements and exhibits
2024-05-10Completed acquisition or disposition of assets · Other events · Financial statements and exhibits
2024-04-15Completed acquisition or disposition of assets · Financial statements and exhibits
2024-03-05Completed acquisition or disposition of assets · Amendments to charter or bylaws · Financial statements and exhibits
2024-02-16Change in certifying accountant
2023-09-18Entry into a material agreement · Completed acquisition or disposition of assets · Unregistered sales of equity securities · Material modification to rights of security holders · Change in control · 5.06 · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…